// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Effects of baricitinib on haematological laboratory parameters in patients with rheumatoid arthritis

Thomas W Huizinga - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Baricitinib

Characteristics of patients treated with biologic monotherapy and combination therapy for moderate or severe rheumatoid arthritis in five European countries

Emma Sullivan - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Monitoring of immunoglobulins in patients with systemic lupus erythematosus treated with rituximab and associated infection risk of hypogammaglobulinaemia

Sean Davidson - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Rituximab

Long-term hydroxychloroquine use: are lupus patients under-monitored? A university teaching hospital experience

Mandy McCartney - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

A critical literature review of the effectiveness and safety of dietary interventions for the treatment of psoriasis and psoriatic arthritis

Rhian Roberts - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Psoriatic arthritis

N/A

Etanercept induced large vessel vasculitis in a patient with rheumatoid arthritis in remission: a case report

Surabhi Wig - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Large vessel vasculitis

Methotrexate

Eosinophilicgranulomatosis with polyangiitis versus hypereosinophilic syndrome: a diagnostic dilemma

Stephen McDonald - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypereosinophilic Syndrome

N/A

Adrenal insufficiency in granulomatosis polyangitis

Thomas Fieldman - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Immune thrombocytopenia

Hydrocortisone

Management of uveitis in adults: working together with rheumatologists

Carlos Pavesio - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Uveitis

Adalimumab

Importance of vertebral fractures

Kassim Javaid - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Inflammation: initiation and maintenance of peripheral and central sensitisation

Marzia Malcangio - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Inflammatory Arthritis

N/A

Occupational outcomes in axial spondyloarthritis

Joanna Shim - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Fatigue’s neural fingerprint

Neil Basu - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

National Arthritis Audit IT portal

James Galloway - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

What do the genetics of psoriatic arthritis tell us about the disease?

Anne Barton - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

N/A

Treating PsA: what is the target, and how can we get there?

Laura Coates - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Assessing and monitoring sleep in people with rheumatic and musculoskeletal disease

Daniel Whibley - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Mining data from the clinical record

Goran Nenadic - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Patient activation: what do I need to know?

Andrew Hunt - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The impact of an in-house rheumatology ultrasound service on patient care and care pathways

George Hirsch - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Early inflammatory arthritis

N/A

Copyright © 2026. QuantiNova All rights reserved